Pactiv evergreen inc. announces receipt of all required regulatory approvals for planned acquisition by novolex

Lake forest, ill., march 28, 2025 (globe newswire) --  pactiv evergreen inc. (“pactiv evergreen” or the “company”) (nasdaq: ptve) today announced that all required regulatory approvals have been received in connection with the company's previously announced definitive agreement to be acquired by novolex® for $18.00 per share in cash.
PTVE Ratings Summary
PTVE Quant Ranking